blogspot counter


Stocks to Buy February 23, 2010

Posted by StocksNoob | Investment | Tuesday 23 February 2010 1:36 am

Stock watch list for tomorrow, February 23, 2010.

AT&T (T: 25.56 0.00%) – This is a huge dividend paying stock that is trading at only $25. This has the potential to go up to $28 by the end of next month.

Bank of America. (BAC: 16.80 0.00%) – I had previously advised to buy this stock when it was trading under $14.50, Look where it is now and it does not seem like it will be stopping anytime soon.

Stocks to Buy February 8, 2010

Posted by StocksNoob | Stock Picks, Stocks to Buy | Sunday 7 February 2010 11:17 pm

Stock Watch list for tomorrow February 8, 2010:

Bank of America Corp. (BAC: 16.80 0.00%) – BAC is trading at $15. I expect it to go higher.

AT&T (T: 25.56 0.00%)- It has a dividend of about 7% and it is trading under $25.25. This stock should make a huge leap in the next couple of days.

Alcoa (AA: 13.67 0.00%) – After initially going red on Friday, Alcoa bounced back and went green. It has a upward momentum, so watch out for Alcoa.

Stocks to Buy February 5, 2010

Posted by StocksNoob | Investment | Friday 5 February 2010 2:05 am

Stock Watch List for tomorrow February 5, 2010:

AT&T (T: 25.56 0.00%) – It is only trading at $25.05.

CSX Corp. (CSX: 49.52 0.00%) – This stock will eventually bounce back.

Stocks to Buy February 3, 2010

Posted by StocksNoob | Stock Picks, Stocks to Buy | Tuesday 2 February 2010 10:04 pm

Stock Watch List for tomorrow, February 3, 2010 are:

Citi Group. (C: 3.82 0.00%) – For the third straight day, Citi closed over the 10 day moving average. It is looking bullish at the moment.

SIRIUS XM Radio Inc. (SIRI: 0.9108 0.00%) – Sirius closed above $0.90 today. It might be on its way to $1.00

Alcoa. Inc. (AA: 13.67 0.00%) – After the “Buy” upgrade from Citi, Alcoa’s share rose 2.32% today. Its likely that Alcoa will continue the uptrend.

Hemispherx Biopharma, Inc. (HEB: 0.7109 0.00%) – Hemispherx Biopharma Received Favorable Notice Via Its Subcontractor That the FDA Seattle District Accepts Ampligen(R) Manufacturing Response.